文献速递骨质疏松与代谢性骨病

实现成功结局的患者激活干预成本:PAADRN随机对照试验结果

The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.
PubMed 文献 · Osteoporos Int · 2017-06-15

在PAADRN实用性随机对照试验中,纳入7749例接受DXA检查的患者,评估个体化DXA结果通知信联合骨健康手册的成本效益。结果显示,实现四项以患者为中心的结局中,每改善一项结局的增量人均成本(每需治疗人数成本)从127.41美元到222.75美元不等。作者认为该干预能以适度成本改善四项以患者为中心的结局。

要点

  • 干预为个体化DXA结果信联合骨健康教育手册,在DXA后4周发送,对照组接受常规护理。
  • 每改善患者正确识别DXA结果的能力,增量人均成本(每需治疗人数成本)为171.07美元。
  • 每改善患者就DXA结果联系提供者,成本为222.75美元;每改善与提供者讨论结果,成本为193.55美元。

核心结论

  • 个体化DXA结果信联合教育手册能以适度成本改善四项以患者为中心的结局。

研究设计与样本

  • PAADRN实用性随机对照试验纳入2012年2月至2014年8月在三个健康中心接受DXA检查的7749例患者,基线及DXA后52周进行访谈。
  • 干预组在DXA后4周收到个体化DXA结果信联合骨健康教育手册,常规护理组未收到。

主要发现

  • 平均年龄66.6岁,女性占83.8%,非西班牙裔白人占75.3%。
  • 每改善患者正确识别DXA结果的能力,增量人均成本(每需治疗人数成本)为171.07美元。
  • 每改善患者就DXA结果联系提供者,成本为222.75美元;每改善与提供者讨论结果,成本为193.55美元。
  • 每实现满意度0.5个标准差改善,成本为127.41美元。

关键数值与推荐

  • 需治疗人数采用意向性治疗线性概率模型确定,增量人均干预成本按人计算,每需治疗人数成本由二者计算得出。
  • 四项以患者为中心的结局分别为:正确识别DXA结果、就DXA结果联系提供者、与提供者讨论DXA结果、对骨健康护理的满意度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In a large, pragmatic clinical trial, we calculated the costs of achieving four successful patient-centered outcomes using a tailored patient activation DXA result letter accompanied by a bone health brochure. The cost to achieve one successful outcome (e.g., a 0.5 standard deviation improvement in care satisfaction) ranged from $127.41 to $222.75. INTRODUCTION: Pragmatic randomized controlled trials (RCTs) should focus on patient-centered outcomes and report the costs for achieving those outcomes. We calculated per person incremental intervention costs, the number-needed-to-treat (NNT), and incremental per patient costs (cost per NNT) for four patient-centered outcomes in a direct-to-patient bone healthcare intervention. METHODS: The Patient Activation after DXA Result Notification (PAADRN) pragmatic RCT enrolled 7749 patients presenting for DXA at three health centers between February 2012 and August 2014. Interviews occurred at baseline and 52 weeks post-DXA. Intervention subjects received an individually tailored DXA result letter accompanied by an educational bone health brochure 4 weeks post-DXA, while the usual care subjects did not. Outcomes focused on patients (a) correctly identifying their results, (b) contacting their providers, (c) discussing their results with their providers, and (d) satisfaction with their bone healthcare. NNTs were determined using intention-to-treat linear probability models, per person incremental intervention costs were calculated, and costs per NNT were computed. RESULTS: Mean age was 66.6 years old, 83.8% were women, and 75.3% were non-Hispanic whites. The incremental per patient cost (costs per NNT) to increase the ability of a patient to (a) correctly identify their DXA result was $171.07; (b) contact their provider about their DXA result was $222.75; (c) discuss their DXA result with their provider was $193.55; and (d) achieve a 0.5 SD improvement in satisfaction with their bone healthcare was $127.41. CONCLUSION: An individually tailored DXA result letter accompanied by an educational brochure can improve four patient-centered outcomes at a modest cost. TRIAL REGISTRATION: clinicaltrials.gov identifier NCT01507662.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Wolinsky FD, Hall SF, Lou Y, et al. The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial. Osteoporos Int. 2017. PMID: 28620779. doi:10.1007/s00198-017-4113-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。